Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LG Uplus is one of South Korea’s largest telecommunications and media companies, providing mobile network services, internet, IPTV, IoT solutions, and corporate ICT services. It operates under the umbrella of the broader LG Corporation. While not a life sciences or pharmaceutical company by core business model, it has entered into partnerships to develop digital healthcare solutions leveraging its communications technology. The company has recently partnered with academic institutions like UNIST to co-develop smart healthcare and digital health monitoring solutions using AI and IoMT technologies. No evidence exists that it develops drugs or therapeutics. As of Q4 2023, it had over 18 million wireless subscribers and remains active in expanding its service offerings in South Korea.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LG Uplus.